We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
-2.22%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
10 Year Est. Return
AUM
$61.5M
AUM Growth
-$1.49M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$386M
$39.3M 63.85%
21,346,829
ACHL
2
DELISTED
Achilles Therapeutics
ACHL
$10.6M 17.26%
11,086,909
FRLN
3
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$10.1M 16.45%
1,466,508
ADAP
4
DELISTED
Adaptimmune Therapeutics
ADAP
$1.5M 2.44%
1,377,294

Similar funds

Syncona Portfolio's Q1 2023 Portfolio in Review

As of Q1 2023, Syncona Portfolio held 4 positions worth $61.5M, down 2.4% from $63M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. Syncona Portfolio opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio's ten largest holdings make up 100% of its $61.5M portfolio in Q1 2023.
  • Syncona Portfolio opened 0 new positions and closed 0 in Q1 2023.
  • Syncona Portfolio's portfolio value fell 2.4% quarter-over-quarter to $61.5M.

Based on Syncona Portfolio's 13F filing for Q1 2023, filed 12 May 2023.